protoporphyrin ix has been researched along with Dermatoses in 14 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of LPDL alone versus LPDL in photodynamic therapy with methylaminolevulinic acid (MAL-LPDL) for acne vulgaris." | 5.13 | Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial. ( Haedersdal, M; Togsverd-Bo, K; Wiegell, SR; Wulf, HC, 2008) |
| "Photodynamic therapy (PDT) for cancer patients has developed into an important new clinical treatment modality in the past 25-years." | 2.40 | 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. ( Berg, K; Giercksky, KE; Kongshaug, M; Moan, J; Nesland, JM; Peng, Q; Warloe, T, 1997) |
| "Methyl nicotinate (MN) is a thermogenic and vasodilating substance that facilitates the topical tissue penetration of some compounds." | 1.56 | MAL-associated methyl nicotinate for topical PDT improvement. ( Bagnato, VS; Buzza, HH; Ciol, H; Inada, NM; Leite, IS; Romano, RA; Stringasci, MD, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Stringasci, MD | 1 |
| Ciol, H | 1 |
| Romano, RA | 1 |
| Buzza, HH | 1 |
| Leite, IS | 1 |
| Inada, NM | 1 |
| Bagnato, VS | 1 |
| Wen, X | 1 |
| Li, Y | 1 |
| Hamblin, MR | 1 |
| Fonda-Pascual, P | 1 |
| Moreno-Arrones, OM | 1 |
| Alegre-Sanchez, A | 1 |
| Saceda-Corralo, D | 1 |
| Buendia-Castaño, D | 1 |
| Pindado-Ortega, C | 1 |
| Fernandez-Gonzalez, P | 1 |
| Velazquez-Kennedy, K | 1 |
| Calvo-Sánchez, MI | 1 |
| Harto-Castaño, A | 1 |
| Perez-Garcia, B | 1 |
| Bagazgoitia, L | 1 |
| Vaño-Galvan, S | 1 |
| Espada, J | 1 |
| Jaen-Olasolo, P | 1 |
| Yang, J | 1 |
| Xia, Y | 1 |
| Liu, X | 1 |
| Jiang, S | 1 |
| Xiong, L | 1 |
| Tyrrell, J | 1 |
| Campbell, SM | 1 |
| Curnow, A | 1 |
| Oh, EK | 1 |
| Jin, SE | 1 |
| Kim, JK | 1 |
| Park, JS | 1 |
| Park, Y | 1 |
| Kim, CK | 1 |
| Valentine, RM | 1 |
| Ibbotson, SH | 1 |
| Wood, K | 1 |
| Brown, CT | 1 |
| Moseley, H | 1 |
| Bäumler, W | 1 |
| Ackermann, G | 1 |
| Abels, C | 1 |
| Szeimies, RM | 1 |
| Silva, JN | 1 |
| Filipe, P | 1 |
| Morlière, P | 1 |
| Mazière, JC | 1 |
| Freitas, JP | 1 |
| Cirne de Castro, JL | 1 |
| Santus, R | 1 |
| Haedersdal, M | 1 |
| Togsverd-Bo, K | 1 |
| Wiegell, SR | 1 |
| Wulf, HC | 1 |
| Peng, Q | 1 |
| Warloe, T | 1 |
| Berg, K | 1 |
| Moan, J | 1 |
| Kongshaug, M | 1 |
| Giercksky, KE | 1 |
| Nesland, JM | 1 |
| Fischer, F | 1 |
| Dickson, EF | 1 |
| Pottier, RH | 1 |
| Wieland, H | 1 |
| Mathews-Roth, MM | 1 |
| Siepker, LJ | 1 |
| Kramer, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fluorescence and Thermal Imaging of the Skin Before and During Photodynamic Therapy[NCT03167762] | 18 participants (Actual) | Interventional | 2017-06-22 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for protoporphyrin ix and Dermatoses
| Article | Year |
|---|---|
Photodynamic therapy in dermatology beyond non-melanoma cancer: An update.
Topics: Acne Vulgaris; Aminolevulinic Acid; Collagen; Humans; Photochemotherapy; Photosensitizing Agents; Po | 2017 |
In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology.
Topics: Dermatology; Humans; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reactive Oxygen Sp | 2016 |
[Fluorescence diagnosis in dermatology].
Topics: Aminolevulinic Acid; Image Processing, Computer-Assisted; Optical Imaging; Protoporphyrins; Skin Dis | 2003 |
Photodynamic therapies: principles and present medical applications.
Topics: Aminolevulinic Acid; Bowen's Disease; Clinical Trials as Topic; Humans; Light; Lipoproteins, LDL; Ma | 2006 |
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
Topics: Aminolevulinic Acid; Forecasting; Heme; Humans; Neoplasms; Photochemotherapy; Protoporphyrins; Resea | 1997 |
Beta-carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adolescent; Adult; Animals; Bacteria; Bacterial Physiological Phen | 1986 |
1 trial available for protoporphyrin ix and Dermatoses
| Article | Year |
|---|---|
Long-pulsed dye laser versus long-pulsed dye laser-assisted photodynamic therapy for acne vulgaris: A randomized controlled trial.
Topics: Acne Vulgaris; Adult; Aminolevulinic Acid; Edema; Erythema; Female; Fluorescence; Humans; Laser Ther | 2008 |
7 other studies available for protoporphyrin ix and Dermatoses
| Article | Year |
|---|---|
MAL-associated methyl nicotinate for topical PDT improvement.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Cell Line; Cell Survival; Humans; Male; NAD; | 2020 |
Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines.
Topics: Aminolevulinic Acid; Cell Death; Cell Line; Deferoxamine; Drug Synergism; Fibroblasts; Humans; Iron | 2010 |
The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy.
Topics: Aged; Air; Air Conditioning; Cold Temperature; Female; Humans; Light; Male; Oxygen; Pain; Pain Manag | 2011 |
Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Cations; Drug Compounding; Drug Stability; In | 2011 |
Modelling fluorescence in clinical photodynamic therapy.
Topics: Aminolevulinic Acid; Humans; Models, Theoretical; Monte Carlo Method; Photobleaching; Photochemother | 2013 |
An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part I. Design, spectral and spatial characteristics.
Topics: Aminolevulinic Acid; Equipment Design; Humans; Image Processing, Computer-Assisted; Photosensitizing | 2001 |
Protoporphyrin accumulation by mitogen stimulated lymphocytes and protoporphyrinogen oxidase activity in patients with porphyria variegata and erythropoietic protoporphyria: evidence for deficiency of protoporphyrinogen oxidase and ferrochelatase in both
Topics: Adult; Aminolevulinic Acid; Child; Edetic Acid; Ferrochelatase; Flavoproteins; Humans; Iron; Liver D | 1985 |